SE8703308L - Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi - Google Patents
Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemiInfo
- Publication number
- SE8703308L SE8703308L SE8703308A SE8703308A SE8703308L SE 8703308 L SE8703308 L SE 8703308L SE 8703308 A SE8703308 A SE 8703308A SE 8703308 A SE8703308 A SE 8703308A SE 8703308 L SE8703308 L SE 8703308L
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- cerebral
- ischemistry
- therapeutic agent
- diseases connected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19879686 | 1986-08-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8703308D0 SE8703308D0 (sv) | 1987-08-26 |
SE8703308L true SE8703308L (sv) | 1988-02-28 |
SE502323C2 SE502323C2 (sv) | 1995-10-02 |
Family
ID=16397046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8703308A SE502323C2 (sv) | 1986-08-27 | 1987-08-26 | Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi |
Country Status (22)
Country | Link |
---|---|
US (1) | US4870090A (sv) |
JP (1) | JPH07121863B2 (sv) |
KR (1) | KR950002151B1 (sv) |
AU (1) | AU603375B2 (sv) |
BE (1) | BE1003959A5 (sv) |
CA (1) | CA1302888C (sv) |
CH (1) | CH672069A5 (sv) |
DE (1) | DE3728499A1 (sv) |
DK (1) | DK171392B1 (sv) |
FI (1) | FI873727A (sv) |
FR (1) | FR2605222B1 (sv) |
GB (1) | GB2195532B (sv) |
HK (1) | HK64993A (sv) |
IE (1) | IE60601B1 (sv) |
IT (1) | IT1211477B (sv) |
LU (1) | LU86973A1 (sv) |
NL (1) | NL8701994A (sv) |
NO (1) | NO873571L (sv) |
NZ (1) | NZ221564A (sv) |
SE (1) | SE502323C2 (sv) |
SG (1) | SG52393G (sv) |
ZA (1) | ZA876401B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
AU1363699A (en) * | 1997-10-23 | 1999-05-10 | National Institute Of Health | Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents |
AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
EP0223811A1 (en) * | 1985-05-22 | 1987-06-03 | Beecham Group Plc | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
US4792564A (en) * | 1986-03-14 | 1988-12-20 | The Medical College Of Wisconsin, Inc. | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2195532A (en) | 1988-04-13 |
ZA876401B (en) | 1988-04-27 |
FI873727A0 (fi) | 1987-08-27 |
DK171392B1 (da) | 1996-10-14 |
FI873727A (fi) | 1988-02-28 |
HK64993A (en) | 1993-07-16 |
IT8767725A0 (it) | 1987-08-21 |
BE1003959A5 (fr) | 1992-07-22 |
NL8701994A (nl) | 1988-03-16 |
GB8720219D0 (en) | 1987-10-07 |
JPS63152317A (ja) | 1988-06-24 |
JPH07121863B2 (ja) | 1995-12-25 |
LU86973A1 (fr) | 1987-12-16 |
NO873571D0 (no) | 1987-08-24 |
SE8703308D0 (sv) | 1987-08-26 |
CH672069A5 (sv) | 1989-10-31 |
CA1302888C (en) | 1992-06-09 |
SG52393G (en) | 1993-08-06 |
IE872218L (en) | 1988-02-27 |
FR2605222A1 (fr) | 1988-04-22 |
DE3728499A1 (de) | 1988-03-03 |
AU7731187A (en) | 1988-03-03 |
IT1211477B (it) | 1989-11-03 |
NZ221564A (en) | 1999-08-30 |
IE60601B1 (en) | 1994-07-27 |
US4870090A (en) | 1989-09-26 |
NO873571L (no) | 1988-02-29 |
DK441987D0 (da) | 1987-08-25 |
KR880002525A (ko) | 1988-05-09 |
FR2605222B1 (fr) | 1991-02-22 |
AU603375B2 (en) | 1990-11-15 |
DK441987A (da) | 1988-02-28 |
GB2195532B (en) | 1990-05-23 |
KR950002151B1 (ko) | 1995-03-14 |
SE502323C2 (sv) | 1995-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO160850C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer. | |
NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
DE3382641T2 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
NO912758D0 (no) | Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
NO874955D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. | |
NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO864130D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater. | |
NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
NO883485D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
NO885598L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser. | |
NO900697D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater. | |
NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
EP0396748A4 (en) | Agent for treating ischemic brain trouble | |
SE8703308L (sv) | Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi | |
NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
NO167456C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre | |
NO172495C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser | |
NO881884L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
DK532087A (da) | Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
NO913644D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
DK320081A (da) | Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater | |
NO165999C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-(2-aminoetyl)benzamid-derivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |